|Day Low/High||105.49 / 112.83|
|52 Wk Low/High||28.00 / 131.00|
Let's look at the cold, hard facts around the vaccine rollout.
Plus, Coinbase files for an eventual initial public offering that should draw a ton of interest.
I fear our legislators see these statistics and misunderstand the plight of the lower to middle class American in this environment.
I am staying away from this name for now, despite the Alexion acquisition and vaccine promise.
Vaccines are on the move (a big plus) even as members of Congress continue to dawdle on a fiscal support package (a big minus).
Plus, stay nimble as the road just ahead could become a bit more treacherous than many may think.
There is little to no fear in the air, relative to what we as investors, and we as a people, have been through.
Most important come Inauguration Day is the seamless transition of leadership over 'Operation Warp Speed'.
The RMPIA also tops other indexes for year, shooting ahead 29%.
Also, Salesforce posts successful quarter and announces Slack acquisition to effectively take on Microsoft.
I think I'll just forget to put a new price target on this name for a while. All of my prior sales were mistakes.
The battle to gain control over Covid-19 is entering a crucial stage and calls for continued determination.
Equity markets have run wild since Oct. 30, and it is the more economically sensitive indices that have really taken flight.
A lot has happened over the past couple weeks, but little has changed. Let's dig in.
Basically, I think we laid out enough reasons for financial markets to revolt, yet they did not.
When Nvidia reports after the bell Wednesday, I'll be focused on three key things.
I'm long MRNA and have been since the beginning of the pandemic.
The only expectation that I have for now is a near certainty in increased volatility caused by several factors.
Look at companies that were decimated by lockdowns in the spring and figure that history is about to repeat itself.
You had better ensure that your cash flow is improving owing to those holdings.
Trading volume was low enough Wednesday to indicate a lack of conviction, or conviction that did not spread across enough managers to truly change the narrative.
Aggressive traders who have dug into the fundamentals of this German-based company could look to go long.
What the Nasdaq experienced Monday is known not just as an 'Outside Day,' but an 'Outside Reversal,' and these can be dangerous.
We are going to win the war, but battles are still ahead. Here's how to invest in the meantime.
Here's how to position yourself now that news of the Pfizer vaccine has landed, and what's happening with the 'haves,' 'have nots' and Treasuries.
The leaders now are suddenly the reopening stocks, while the work remotely and stay at home stocks are being sold.
The focus when it comes to MRNA is the timing of mRNA-1273, the firm's two dose hopeful protection against Covid.